Invent Medic Sweden AB (XSAT:IMS) Cyclically Adjusted FCF per Share: kr-0.62 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Invent Medic Sweden AB Cyclically Adjusted FCF per Share?

Invent Medic Sweden AB XSAT:IMS -0.54% Cyclically Adjusted FCF per Share is kr-0.62 as of Mar. 2026. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Invent Medic Sweden AB's adjusted free cash flow per share for the three months ended in Mar. 2026 was kr-0.017. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr-0.62 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-18), Invent Medic Sweden AB's current stock price is kr0.0915. Invent Medic Sweden AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was kr-0.62. Invent Medic Sweden AB's Cyclically Adjusted Price-to-FCF of today is .


Invent Medic Sweden AB  (XSAT:IMS) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Invent Medic Sweden AB Cyclically Adjusted FCF per Share Related Terms


Invent Medic Sweden AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Invent Medic Sweden AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invent Medic Sweden AB Cyclically Adjusted FCF per Share Chart

Invent Medic Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.63

Invent Medic Sweden AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.62 -0.63 -0.62

XSAT:IMS vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Invent Medic Sweden AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invent Medic Sweden AB Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Invent Medic Sweden AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Invent Medic Sweden AB's Cyclically Adjusted Price-to-FCF falls into.



Invent Medic Sweden AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Invent Medic Sweden AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.017/133.5600*133.5600
=-0.017

Current CPI (Mar. 2026) = 133.5600.

Invent Medic Sweden AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.084 101.019 -0.111
201609 -0.084 101.138 -0.111
201612 -0.120 102.022 -0.157
201703 -0.136 102.022 -0.178
201706 -0.172 102.752 -0.224
201709 -0.109 103.279 -0.141
201712 -0.243 103.793 -0.313
201803 -0.211 103.962 -0.271
201806 -0.212 104.875 -0.270
201809 -0.107 105.679 -0.135
201812 -0.224 105.912 -0.282
201903 -0.252 105.886 -0.318
201906 -0.231 106.742 -0.289
201909 -0.204 107.214 -0.254
201912 -0.200 107.766 -0.248
202003 -0.198 106.563 -0.248
202006 -0.228 107.498 -0.283
202009 -0.204 107.635 -0.253
202012 -0.231 108.296 -0.285
202103 -0.198 108.360 -0.244
202106 -0.215 108.928 -0.264
202109 -0.220 110.338 -0.266
202112 -0.183 112.486 -0.217
202203 -0.149 114.825 -0.173
202206 -0.130 118.384 -0.147
202209 -0.063 122.296 -0.069
202212 -0.082 126.365 -0.087
202303 -0.049 127.042 -0.052
202306 -0.030 129.407 -0.031
202309 -0.045 130.224 -0.046
202312 -0.043 131.912 -0.044
202403 -0.049 132.205 -0.050
202406 -0.017 132.716 -0.017
202409 -0.022 132.304 -0.022
202412 -0.054 132.987 -0.054
202503 -0.014 132.825 -0.014
202506 -0.011 133.699 -0.011
202509 -0.013 133.480 -0.013
202512 -0.003 133.390 -0.003
202603 -0.017 133.560 -0.017

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr-0.62 mean?
Invent Medic Sweden AB (XSAT:IMS) has a Cyclically Adjusted FCF per Share of kr-0.62 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Invent Medic Sweden AB and its competitors.
Is Invent Medic Sweden AB's Cyclically Adjusted FCF per Share too high?
Invent Medic Sweden AB's current Cyclically Adjusted FCF per Share is kr-0.62.
How does Invent Medic Sweden AB's Cyclically Adjusted FCF per Share compare to ABT and SYK?
Invent Medic Sweden AB's Cyclically Adjusted FCF per Share of kr-0.62 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Invent Medic Sweden AB and its competitors. Invent Medic Sweden AB's current Cyclically Adjusted FCF per Share is kr-0.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invent Medic Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Invent Medic Sweden AB (XSAT:IMS) is currently considered Significantly Undervalued. The stock's GF Value™ is kr0.18, compared to a current price of kr0.09 — trading 49.2% below its estimated fair value. The current Cyclically Adjusted FCF per Share is kr-0.62. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Invent Medic Sweden AB (XSAT:IMS), the current Cyclically Adjusted FCF per Share is kr-0.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Invent Medic Sweden AB Business Description

Address Nytenkargatan 4, Lund, SWE, 223 63
Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.